Microbiology Nuts & Bolts
  • Home
  • Basic Concepts
    • What is infection?
    • Normal flora
    • Diagnosing infection
  • Microbiology
    • Basic bacterial identification
    • Interpreting bacteriology results
    • Interpreting serology results
  • Infection Control
    • What is infection control?
    • Universal precautions
    • MRSA
    • Clostridium difficile
  • Clinical Scenarios
    • Respiratory infections
    • Urinary infections
    • GI infections >
      • D&V
      • CDAD
    • CNS infections
    • Skin & bone infections
    • Sepsis
  • Antibiotics
    • Antimicrobial Stewardship
    • How antibiotics work
    • How to choose an antibiotic?
    • Reviewing antibiotics
    • Antibiotic resistance
    • Testing antibiotic resistance
    • Penicillin allergy
    • Theraputic Drug Monitoring
  • Guidelines
  • Lectures & Lecture Notes
    • Medical Students
    • Curriculum for the Foundation Program
    • Foundation Year 1
    • Foundation Year 2
    • Other Lectures
  • The Bug Blog
  • Buy the book...
  • NEW Edition Updates
  • Peer Reviews
  • Want to know more?
  • Contact

It’s not all Pros for Procalcitonin

1/12/2016

 
Previously I blogged about the use of antibiotics in pancreatitis and I mentioned procalcitonin as an exciting new marker of infection. I have little experience of this laboratory test but have heard many others talk about how useful it is. But what is it? What is it useful for? Can it help in the diagnosis and management of infection?
 
What is procalcitonin?
Procalcitonin (PCT) is a protein produced by the thyroid, lungs and intestine in response to inflammation, especially when the inflammation is caused by bacterial infection. In contrast, levels of PCT do not increase much when inflammation is caused by viruses or most non-infectious causes. Levels increase quickly (within 2-4 hours) and have a half-life of 24-36 hours. It is suggested (by the manufacturers of the PCT assay machines) that PCT can therefore be used to identify septic patients and predict who is at risk of developing severe sepsis. The amount of PCT is said to be related to the amount of inflammation therefore in theory the level of PCT can also be used to monitor response to treatment; a decrease in PCT corresponding to a favourable response to treatment.
​How is procalcitonin measured?
PCT is measured on an analyser. This assay/machine is not currently widely available in the UK but this is changing. The assay is performed on a serum sample taken from a vein and collected in a red or yellow vacutainer. A minimum volume of 0.25mL serum is usually required; which corresponds to 0.5mL blood. 
Measuring procalcitonin (PCT)
Guess I'm measuring the wrong PCT! ...Wishful thinking.
​According to the Association of Clinical Biochemists UK the normal range of PCT in adults is ≤ 0.05 ng/mL and the ranges for diagnosing pneumonia and sepsis are below. Raised levels need to be interpreted in the clinical context of the patient. If the patient does not clinically have an infection then don’t do a PCT, you won’t be able to interpret the result because there are no criteria for interpreting PCT in the absence of an infection e.g. if the PCT is 1.0 ng/mL and the patient has no infection then what does this mean? Also, in order to use the pneumonia criteria below the patient does have to have evidence of pneumonia such as consolidation on a chest x-ray, the PCT values do not apply if the chest x-ray is normal; all the PCT will “help” with is deciding if the pneumonia is bacterial or viral or deciding to give shorter durations of treatment… but which of us will be brave enough to do that? Do you trust a PCT result over the standard treatment of 7 days for pneumonia and decades of clinical experience with this?

If a diagnosis of pneumonia is suspected:
Absence of infection:
PCT < 0.1 ng/mL ​
Bacterial infection unlikely:
PCT ≥ 0.1–< 0.25 ng/mL
Bacterial infection possible: ​
​PCT ≥ 0.25–< 0.5 ng/mL
​Suggestive of bacterial infection:
​PCT ≥ 0.5 ng/mL
​If a diagnosis of systemic bacterial infection or sepsis is suspected:
Systemic infection
​unlikely:
​PCT < 0.5 ng/mL
Systemic infection
​possible:
​PCT ≥ 0.5– < 2 ng/mL
​Systemic infection
​likely:
​PCT ≥ 2 ng/mL
​Severe sepsis or septic ​shock likely:
PCT ≥ 10 ng/mL
Is it just me or are there a lot of “unlikelys”, “possibles” and “likelys” in these ranges?! To me, the maybe maybe-not approach is not really very helpful. It also means another set of baffling ranges to remember especially when you factor in the need to remember a different range for each condition!
 
Another problem with PCT is that is not actually 100% sensitive or specific. Localised infections and most non-infectious inflammatory conditions do not give a raised PCT but high PCTs can occur in some non-infectious conditions such as severe trauma, major surgery or cardiogenic shock; remember PCT is measuring a response to inflammation.
 
How should procalcitonin be used in acute pancreatitis?
I originally looked at procalcitonin as a potential help in diagnosing infected pancreatic necrosis, so how useful could it be in this condition?
 
It has been proposed that a cut off of 1.8ng/mL on 2 consecutive days can be used to predict infected necrosis with sensitivity of 95% and specificity of 88%. A few years later the same authors proposed a cut off of >3.5ng/mL on 2 consecutive days with a sensitivity of 93% and specificity of 88%. So which is it; 1.8ng/mL or 3.5ng/mL? There are only a few papers using PCT in diagnosing infected pancreatic necrosis and it is clear there’s still work to be done. A test that fails to spot 5-7 out of 100 patients with infected necrosis is of limited use on its own.
 
In practice the PCT would not be used in isolation for diagnosing infected pancreatic necrosis but rather within the clinical context. The PCT would be looked at in conjunction with the physiological parameters of the patient such as heart rate, respiratory rate, blood pressure and other blood tests such as C-reactive protein (CRP), the peripheral white blood cell (WBC) count and serum lactate. Finally, if there is any doubt about the diagnosis then either a CT-guided FNA should be done or empirical treatment started.
 
There is another significant drawback in the measurement of PCT in pancreatitis and that is that the test does not provide accurate assessment in patients with raised bilirubin levels as the colour interferes with the reading of the test, giving false results. This is a real shame as many pancreatitis patients are jaundiced due to gallstone obstruction of the bile ducts.
 
What about the claims for predicting sepsis and the severely septic patient?
Whilst researching this topic I came across a fantastic video from Dr James Faix, Associate Professor of Pathology at Stamford University in the USA, which was recorded in 2012. Research in this area has probably moved on a bit in the last 4 years but this really is a good summary of the use of PCT in sepsis.
 
I would add two points to this summary:
  1. The value of PCT has been shown in predicting whether someone with sepsis might go on to develop severe sepsis
  2. There are still a number of patients who will have a negative PCT who still develop severe sepsis (Negative Predictive Value) and some who have a positive PCT who do not develop severe sepsis (Positive Predictive Value); over treating those who don’t go on to develop severe sepsis is not really a problem as it is a safe approach but not treating some who go on to develop severe sepsis through over reliance on a PCT result is a problem (see graph below for NPV and PPV in predicting severe sepsis)
Picture
The promotional material from the companies who produce the PCT assays suggest it should be used in the diagnosis of sepsis but this is not what NICE or the Surviving Sepsis Campaign say. NICE state “there was not enough evidence to recommend that these tests are used in the NHS”. The Surviving Sepsis Campaign suggest that “low procalcitonin levels or similar biomarkers [can be used] to assist the clinician in the discontinuation of empiric antibiotics in patients who initially appeared septic, but have no subsequent evidence of infection” but they clarify this by also saying “clinical experience with this strategy is limited and the potential for harm remains a concern”. Draw your own conclusions!
 
Should I rush out and buy a procalcitonin assay for my laboratory?
Well the answer to this is what do you want to use it for? Gosh, Microbiologists never answer the question posed, always presenting another one of their own! If you are looking for the magic test which tells you if a patient has sepsis or infected pancreatic necrosis then forget it, PCT does not do this with sufficient accuracy to be the means by which you tell if a patient is septic or not (see would you recognise a sick patient, sepsis blog).
 
Personally I’m not convinced it provides much more information than a carefully taken medical history, examination and more conventional blood tests in terms of telling how sick a patient is, but then I have little experience of the test in the clinical setting. I don’t think we need to rely solely on chemical markers to diagnosis sick patients and I’m not going to be rushing out and ordering a load of PCTs on my patients just yet.  In fact The Association for Clinical Biochemistry conclude “CRP is a routinely available non-specific marker of inflammation, whose usefulness is not superseded by PCT. However, the use of PCT and CRP in parallel may improve the specificity and sensitivity of the diagnosis of bacterial infection/sepsis”. I agree.
 
Do you have any experience of procalcitonin in clinical practice? What do you think of it? How do you use it? Let me know what you think.     
KDonnelly
16/12/2016 01:14:29 am

Interesting, we are due to start a pilot study for introducing PCT on our ITU unit - do you think it has better utility for a critically ill cohort as compared to a unselected group?


Comments are closed.

    RSS Feed

    Facebook has deleted the Microbiology Nuts & Bolts pages - if you want your weekly dose of microbiology then you will need to come here, and we look forward to you continuing to read it!

    Blog Author:

    David Garner
    Consultant Microbiologist
    Surrey, UK

    Please DO NOT advertise products and conferences on our website or blog

    Categories

    All
    Antibiotic Resistance
    Antibiotics
    Basic Concepts
    Clinical Scenarios
    Guidelines
    Infection Control
    In The News
    Microbiology

    Archives

    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    October 2013
    September 2013
    August 2013
    July 2013

    Categories

    All
    Antibiotic Resistance
    Antibiotics
    Basic Concepts
    Clinical Scenarios
    Guidelines
    Infection Control
    In The News
    Microbiology

    RSS Feed

Powered by Create your own unique website with customizable templates.